DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,755 filers reported holding DANAHER CORPORATION in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $3,624,000 | +17.2% | 13,504 | -1.7% | 2.42% | +9.2% |
Q1 2021 | $3,092,000 | -1.7% | 13,739 | -2.9% | 2.21% | -3.3% |
Q4 2020 | $3,144,000 | -2.8% | 14,155 | -5.8% | 2.29% | -13.5% |
Q3 2020 | $3,234,000 | +17.6% | 15,020 | -3.5% | 2.65% | +7.2% |
Q2 2020 | $2,751,000 | +24.5% | 15,560 | -2.5% | 2.47% | +11.1% |
Q1 2020 | $2,209,000 | -10.6% | 15,960 | -0.8% | 2.22% | +18.0% |
Q4 2019 | $2,470,000 | +5.2% | 16,091 | -1.1% | 1.88% | +1.7% |
Q3 2019 | $2,349,000 | -0.3% | 16,266 | -1.3% | 1.85% | -0.4% |
Q2 2019 | $2,356,000 | +5.8% | 16,486 | -2.2% | 1.86% | +4.6% |
Q1 2019 | $2,226,000 | +23.6% | 16,861 | -3.4% | 1.78% | +8.6% |
Q4 2018 | $1,801,000 | -5.8% | 17,461 | -0.7% | 1.64% | +7.2% |
Q3 2018 | $1,911,000 | +10.1% | 17,586 | 0.0% | 1.53% | +1.9% |
Q2 2018 | $1,735,000 | +4.6% | 17,586 | +3.8% | 1.50% | +3.4% |
Q1 2018 | $1,658,000 | +10.3% | 16,936 | +4.6% | 1.45% | +17.1% |
Q4 2017 | $1,503,000 | – | 16,194 | – | 1.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
Third Point | 2,900,000 | $954,129,000 | 6.66% |
Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |